US20090181114A1 - Chia seed beverage and related method - Google Patents

Chia seed beverage and related method Download PDF

Info

Publication number
US20090181114A1
US20090181114A1 US12/349,123 US34912309A US2009181114A1 US 20090181114 A1 US20090181114 A1 US 20090181114A1 US 34912309 A US34912309 A US 34912309A US 2009181114 A1 US2009181114 A1 US 2009181114A1
Authority
US
United States
Prior art keywords
beverage
seed
protein
resulting
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/349,123
Other languages
English (en)
Inventor
John A. Minatelli
W. Stephen Hill
Rudi Moerck
Uy Nguyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Nutraceuticals LLC
Original Assignee
US Nutraceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Nutraceuticals LLC filed Critical US Nutraceuticals LLC
Priority to US12/349,123 priority Critical patent/US20090181114A1/en
Priority to PCT/US2009/030577 priority patent/WO2009089432A1/fr
Assigned to U.S. NUTRACEUTICALS LLC DBA VALENSA INTERNATIONAL reassignment U.S. NUTRACEUTICALS LLC DBA VALENSA INTERNATIONAL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MOERCK, RUDI, HILL, W. STEPHEN, MINATELLI, JOHN A., NGUYEN, UY
Publication of US20090181114A1 publication Critical patent/US20090181114A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/48Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L25/00Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
    • A23L25/30Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/198Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)

Definitions

  • the present invention relates to the field of chia seed products and derivatives of chia seed products and related methods and uses, for example, beverages formed from chia seeds.
  • soybean seed contains very low levels of polyunsaturated fatty acid esters (PUFA's) specifically removed by processes such as partial or total hydrogenation of the oil, which removes mono and polyunsaturated fatty acid esters.
  • PUFA's polyunsaturated fatty acid esters
  • the resulting flour or oil which could be partially defatted, is suitable for cooking fried foods because the resulting oil is heat stable due to its lack of polyunsaturated fatty acid esters.
  • the resulting partially defatted flour is also processed under heat to remove the majority of the remaining fatty acid ester oils and is used extensively in bakery applications either alone or in combination with the phospholipids derived from the processing of soybeans and/or small portions of refined soy oil free of polyunsaturated fatty acid esters.
  • Typical products include Bakers Soy Flour and Soylec sold by Archer Daniels Midland, for example.
  • Flax such as flax seed
  • Flax seed has also been cultivated and used extensively for hundreds of years as a plant based source of oils rich in the fatty acids esters of alpha-linoleic acid and linoleic acid.
  • this seed e.g., the seed's meal
  • a typical use of flax seed oil is in the production of linseed oil, which is a readily air polymerized oil and widely known for its use in oil based paints, furniture finishing applications and for the production of the flooring product commonly known as linoleum.
  • flax seed or flax seed meal is generally not considered to be a good plant based source of protein or fiber due to its toxic components, antagonists and estrogenic lignans found in the seed meal.
  • Whey protein has also been used as a dietary supplement composition. It is the name for a collection of globular protein that can be isolated from whey, a by-product of cheese manufactured from cowls milk. It is typically a mixture of beta-lactoglobulin ( ⁇ 65%), alpha-lactalbumin ( ⁇ 25%), and serum albumin ( ⁇ 8%), which are soluble in their native forms, independent of pH. Whey has the highest Biological Value (BV) of any known protein.
  • BV Biological Value
  • the protein fraction in Whey (approximately 10% of the total dry solids within Whey) comprises four major protein fractions and six minor protein fractions.
  • the major protein fractions in whey are beta-lactoglobulin, alpha-lactalbumin, bovine serum albumin and immunoglobulins. Each of these components have important disease-fighting effects.
  • whey protein is easily digestible.
  • Whey protein can be denatured by heat.
  • High heat like the sustained high temperatures above 72 degrees Celsius (160 degrees Fahrenheit) associated with the pasteurization process denatures whey proteins, destroying some bioactive compounds, such as the amino acid cysteine.
  • native whey protein does not aggregate upon renneting or acidification of milk, denaturing the whey protein triggers hydrophobic interactions with other proteins, and the formation of disulfide bonds between whey proteins and casein micelles, leading to aggregation with other milk proteins at low pH.
  • Whey protein typically comes in three major forms: concentrate, isolate and hydrolysate.
  • Whey protein concentrates contain a low level of fat and cholesterol but generally have higher levels of bioactive compounds, and carbohydrates in the form of lactose—they are 29%-89% protein by weight.
  • Isolates are processed to remove the fat, and lactose, but are usually lower in bioactive compounds as well—they are 90%+protein by weight. Both of these types are mild to slightly milky in taste.
  • Hydrolysates are predigested, partially hydrolyzed whey proteins which consequently are more easily absorbed, but their cost is generally higher.
  • Whey protein hydrolysate also tends to taste quite different than other forms of whey protein, usually in a way that many find undesirable but can be masked when used in beverages.
  • whey protein powder is commonly used by bodybuilders and other athletes to accelerate muscle development and aid in recovery.
  • Some individuals with suppressed or otherwise abnormal immune systems or degenerative diseases use undenatured bioactive whey proteins to increase their antioxidant levels.
  • Undenatured whey proteins are a good source of cysteine, a conditionally essential amino acid which is the rate limiting factor for the body's production of glutathione, an important antioxidant.
  • whey proteins examples include those available in most health food stores and supermarket health sections. They typically are formed of isolate/concentrate or isolate/concentrate/hydrolysate mixtures and are usually flavored so they can be mixed with water or milk and consumed as a drink or shake. However, whey protein contains little or no soluble or insoluble fiber and no PUFA content. Other diet avenues are desirable.
  • Salvia hispanica L. is a known, yet ancient, cultivated seed that was consumed by the Aztec and Mayan cultures where it was a highly prized food staple.
  • their well balanced diet consisted primarily of corn, beans, amaranth and chia seed.
  • chia seed is a critical component of the well known “Chia Pet” due to the seed's ability to readily absorb and retain moisture, its high level of germination and its sticky muco-polysaccharide outer seed coating.
  • these cultures In addition to consuming the whole seed, these cultures also prepared a ready-to-drink, non-shelf stable (thus unstable) beverage by mixing chia seed with various fruit juices including, for example, lime juice in a ratio of approximately 1:12 to 1:30 seed to juice wt/wt ratios with or without the addition of sugar.
  • various fruit juices including, for example, lime juice in a ratio of approximately 1:12 to 1:30 seed to juice wt/wt ratios with or without the addition of sugar.
  • the product which is still made today locally in Central and South America, is commonly referred to as “Chia Fresca”. It is unstable, however.
  • Salvia hispanica L. is known to contain high natural levels of the essential polyunsaturated fatty acid triglycerides of alpha-linolenic acid (“ALA”) an “omega-3” fatty acid and linoleic acid (“LA”), an essential “omega-6” fatty acid, in a unique ratio of approximately 3.3:1.
  • the seed provides approximately 33% seed oil, 21% protein, 41% total dietary fiber and high levels of minerals such as calcium, iron, magnesium and phosphorus.
  • the total composition of chia seed is well known to those skilled in the art.
  • this seed unlike flax seed, contains no gluten, cyanogenic glycosides, lignans or vitamin B antagonists. Therefore chia seed is an excellent source of essential polyunsaturated fatty acids, protein, fiber and minerals.
  • the seed crop was destroyed during the Spanish conquest of the Central American cultures to interrupt the food supply. Only in recent years have agronomists successfully re-cultivated this re-emerging seed for use in “Chia Pets” and more recently as a viable source of the plant-based essential fatty acids, e.g., ALA and LA.
  • the seed has unique benefits of high levels of the essential fatty acid esters of ALA and LA, protein, both soluble and insoluble dietary fiber, and high levels of calcium, potassium, magnesium and phosphorus.
  • An advantage is the seed typically contains no cyanogenic glycosides, Vitamin B antagonists or the phytoestrogenic lignans found in Flax seed. This makes the Salvia Hispanic L.
  • Some commercial operators hydrate and separate seed coat polysaccharide from water pre-soaked seeds to derive a separated seed gel coat useful in the preparation of gel enhanced beverages and later apply the whole seed for the treatment and prevention of human diseases.
  • the operators also produce expeller pressed flour from Salvia hispanica L seed, which is used either alone or admixed with other grain or legume seed flours, meat based seasonings, vegetable based pastes, diary-based products and the like.
  • a beverage is effective for enhancing gastrointestinal regularity and heart health. It is formed by a liquid comprising fruit derived juices, water, or naturally or artificially flavored water. A composition of matter is mixed within the liquid in a shelf stable pasteurized beverage form, and formed from sterilized whole seed extracted from Salvia hispanica L. The resulting beverage exhibits a pH dependent viscosity requiring no additional thickening agents and is suitable as a beverage for human consumption.
  • the beverage includes a preservative for enhancing shelf life and a sweetener such as formed from sucrose, fructose, corn syrup or an artificial sweetener.
  • a sweetener such as formed from sucrose, fructose, corn syrup or an artificial sweetener.
  • the composition of matter that is mixed within the liquid is derived from the sterilized whole seed extracted from Salvia hispanica and includes protein, polyunsaturated essential fatty acid triglycerides, minerals and fiber in a therapeutically effective amount useful for maintaining gastrointestinal system regularity and delivering heart healthy polyunsaturated fatty acids, protein and minerals requiring no additional thickening agents.
  • the protein, polyunsaturated essential fatty acid triglycerides and minerals and fiber are in an effective amount for controlling hunger via satiety and requiring no additional thickening agents to effect such satiety.
  • a method of manufacturing the beverage is set forth by sterilizing clean chia seed to prevent unwanted germination and pre-soaking the seed in water at a ratio of from about 1:9 to about 1:30 wt/wt of seed to water and from between about 5 to about 25 degrees Centigrade for about 3 to about 24 hours to effect adsorption of the water by the seed and form a gel-like outer coating on each seed and permit associated beverage thickening.
  • the method includes adding the presoaked seeds to a fruit juice, containing one or more sweeteners or preservatives or any combination thereof. This can be followed by pasteurizing to form a final shelf stable beverage.
  • the beverage can be bottled.
  • the whole seed is added directly to dissolved beverage ingredients and stirred from between about 1 to about 24 hours at between about 5 to about 25 degrees Centigrade to effect gel coat formation of the seed and associated beverage thickening. This can be followed by flash or conventional pasteurization to prevent any post bottling seed germination and enhancing shelf life without requiring additional thickening agents.
  • the beverage is thickened by adding one or more acidulants to bring the pH of the final beverage to between about 3 to about 6.5. At least one of various lipophilic or hydrophilic ingredients can be added.
  • a composition of matter is mixed therewith and comprises a stable, partially or wholly defatted whole grain meal, derived from Salvia hispanica L. whole ground seed, using a suitable solvent as supercritical carbon dioxide and containing about a 3.0 to about 3.3:1 mixture of essential fatty acid esters of ALA and LA (Polyunsaturated fatty acids “PUFA's”), admixed with lipophilic or hydrophilic additives.
  • PUFA's Polyunsaturated fatty acids
  • the total lipophilic content is between from about 0 to about 25 wt/wt percent of the resulting meal weight and the resulting hydrophilic content is between about 0 and about 10 wt/wt percent of the resulting meal with protein, soluble and insoluble fiber and fructo-oligosaccarides free of cyanogenic glycosides, vitamin B antagonists, lignans and gluten.
  • the method includes preparing liquid concentrates or dried pre-mixes, including protein shakes, fruit smoothies, ready-to-drink beverages, dry beverage pre-mixes, frozen fruit concentrates, aqueous alcoholic beverage pre-mixes, concentrates or their dried pre-mixes, vitamin, carbohydrate and protein fortified meal replacement beverages, drinkable dairy and non-dairy yogurts, gravies and dry gravy pre-mixes, and ready-to-drink and dried pre-mixed infant formulas.
  • liquid concentrates or dried pre-mixes including protein shakes, fruit smoothies, ready-to-drink beverages, dry beverage pre-mixes, frozen fruit concentrates, aqueous alcoholic beverage pre-mixes, concentrates or their dried pre-mixes, vitamin, carbohydrate and protein fortified meal replacement beverages, drinkable dairy and non-dairy yogurts, gravies and dry gravy pre-mixes, and ready-to-drink and dried pre-mixed infant formulas.
  • partially defatted whole grain flour resulting from a partial solvent based extraction of pre-milled Salvia hispanica L. seed, though containing significant quantities of polyunsaturated oils, including essential polyunsaturated fatty acid esters of ALA and LA, is stable.
  • This resulting flour's stability serves as an excellent, stable delivery platform for the essential fatty acid esters of ALA, LA, protein, soluble and insoluble fiber, minerals such as calcium, potassium, magnesium and phosphorus, and both lipophilic and hydrophilic additives, which is free of cyanogenic glycosides, vitamin B antagonists, lignin and gluten.
  • the resulting product can be used as a food ingredient in a beverage and as a dietary supplement ingredient to various foods. It can provide beneficial results in enhancing gastrointestinal regularity and heart health.
  • the resulting partially defatted whole grain flour exhibits an ability to reabsorb large quantities of lipophilic as well as hydrophilic additives while exhibiting a pH dependent thixotropic effect in aqueous environments.
  • the flour as a composition is a novel and inventive food or beverage or dietary supplement ingredient delivery vehicle for lipophilic and hydrophilic additives in the presence of protein, fiber, various levels of the essential fatty acid esters of ALA and LA and minerals that are free of cyanogenic glycosides, vitamin B antagonists, lignin and gluten.
  • the composition of matter enhances the protein, fiber, mineral content and pH controlled viscosity of beverages and their liquid concentrates, dried beverage pre-mixes including protein shakes and fruit smoothies, ready-to-drink beverages, beverage pre-mixes, frozen fruit concentrates, alcoholic beverage dry pre-mixes and concentrates, meal replacement beverages, drinkable dairy and non-dairy yogurts, gravies and dry gravy pre-mixes, and ready to drink and dried pre-mixed infant formulas.
  • the composition of matter can be formed from wholly or partially defatted Salvia hispanica L. whole ground grain meal obtained by supercritical fluid extraction of Salvia hispanica L. ground seeds.
  • supercritical CO 2 fluid solvent extraction of pre-ground Salvia hispanica L. seed alone or in the presence of a mixture of hydrophilic and/or lipophilic antioxidants is used to obtain a wholly or partially defatted whole grain meal containing variable amounts of the stabilized essential polyunsaturated fatty acid esters of ALA and LA (omega-3 and omega-6 esters) and optionally containing either non-native Salvia hispanica L. derived lipophilic or hydrophilic additives. It is useful in a number of food applications.
  • the resulting seed meal provides a unique blend of protein, insoluble and soluble fiber, and variable amounts of the essential fatty acid triglycerides of alpha-linolenic acid (omega-3, “ALA”) and linoleic acid (omega-6, “LA”) in a desirable and unique ratio of approximately 3.3:1.0 ALA to LA, along with high levels of calcium, potassium, magnesium and phosphorus that is free of cyanogenic glycosides, lignans vitamin B antagonists and gluten.
  • ALA alpha-linolenic acid
  • LA linoleic acid
  • the resulting flour can be incorporated into beverages, dry beverage pre-mixes, liquid or frozen beverage concentrates and the like with the added feature of pH controlled viscosity by either the amount of Salvia hispanica L. derived meal that is added and/or by optionally lowering the pH with an acidulant to improve further the viscosity of the resulting beverage.
  • composition of matter in this example is formed from a stable, partially or wholly defatted whole grain meal derived from Salvia hispanica L. whole ground seed using a suitable solvent such as supercritical carbon dioxide. It is rich in minerals. In one aspect, it contains about a 3.0 to about 3.3:1 mixture of essential fatty acid esters of ALA and LA (Polyunsaturated fatty acids “PUFA's”), and is optionally admixed with lipophilic or hydrophilic additives, such that the total lipophilic content is between from about 0 to about 25 wt/wt percent of the resulting meal weight and the resulting hydrophilic content is between about 0 and about 10 wt/wt percent of the resulting meal, protein, soluble and insoluble fiber and fructo-oligosaccarides and free of cyanogenic glycosides, vitamin B antagonists, lignans and gluten. It can be used to prepare a beverage, beverage concentrate or dried beverage pre-mix ingredient.
  • the composition as formed is added to a beverage, liquid concentrate, or dried beverage pre-mixes.
  • the composition can be used for prepared beverages, their liquid concentrates, and dried pre-mixes, including protein shakes, fruit smoothies, ready to drink beverages, dry beverage pre-mixes, frozen fruit concentrates, aqueous alcoholic beverage pre-mixes, concentrates or their dried pre-mixes, vitamin, carbohydrate and protein fortified meal replacement beverages, drinkable dairy and non-dairy yogurts, gravies and dry gravy pre-mixes, and ready to drink and dried pre-mixed infant formulas.
  • the composition with such uses can include added lipophilic additives and added hydrophilic additives.
  • the pH range can be adjusted with the addition of one or more acidulants to bring the pH of the final product to a pH of from about 3 to about 6.5 to further thicken the resulting beverage.
  • composition of matter as described and used can be prepared in a pasteurized beverage form. In its use, it is shelf stable and contains sterilized whole seed from Salvia hispanica L. in an admixture with a wide range of liquid beverage components, including but not limited to, for example, fruit derived juices, water or natural or artificially flavored water such as colas, coffees, teas and the like. It can contain a sweetener such as sucrose, fructose corn syrup or an artificial sweetener. It can also contain preservatives such as sodium benzoate and such other additives common to beverage formulations. The resulting beverage exhibits a pH dependent viscosity. The resulting beverage is also rich in fiber and is particularly useful for maintaining good gastrointestinal system regularity in a convenient and tasty beverage form while delivering heart healthy polyunsaturated fatty acids, protein and minerals.
  • clean chia seed is in a first step sterilized to prevent unwanted germination.
  • the sterilization of seed can be accomplished by flash steam treatment of the seed, by radiation and similar processes.
  • the seed is then pre-soaked in water in one example at a ratio of from about 1:9 to about 1:30 wt/wt seed to water for a period of time to effect adsorption of the water by the seed and form a gel-like outer coating on each seed.
  • Typical time required for such outer gel coat formation is typically from between about 3 to about 24 hours at about 5 to about 25 Degrees Centigrade depending on the desired beverage characteristics.
  • the pre-soaked seeds are added, for examples to a fruit juice optionally containing one or more sweeteners, and/or preservatives to prepare the final beverage for pasteurization with a seed-to-juice ratio of from about 1:12 to about 1:50 wt/wt in this example.
  • the beverage can be added to pre-washed containers and pasteurized to form the final shelf stable beverage.
  • the beverage may be prepared by adding whole seed directly to the other beverage ingredients dissolved in water artificially or naturally flavored water or fruit juice, and optionally stirring from about 1 to about 24 hours and between about 5 to about 25 Degrees Centigrade to effect gel coat formation of the seed and associated pH dependent beverage thickening.
  • the resulting beverage mixture is conventionally or flash pasteurized to prevent post bottling seed germination and enhance shelf life.
  • the composition of matter is in a shelf stable pasteurized beverage form and contains sterilized whole seed from Salvia hispanica L. in an admixture with a wide range of liquid beverage components, including but not limited to, fruit derived juices, water or naturally or artificially flavored water such as colas, coffees, teas and the like. It can contain a sweetener such as sucrose, fructose corn syrup or an artificial sweetener, and contain preservatives such as sodium benzoate and such other additives common to beverage formulations.
  • the resulting beverage exhibits a pH dependent viscosity requiring no additional thickening agents.
  • the beverage can be enriched in protein, polyunsaturated essential fatty acid triglycerides, minerals and rich in fiber particularly useful for maintaining good gastrointestinal system regularity in a convenient and tasty beverage form while delivering heart healthy polyunsaturated fatty acids, protein and minerals requiring no additional thickening agents. It can be useful for the control of hunger via satiety requiring no additional thickening agents to effect such satiety.
  • Example 1 A similar method of manufacturing as described relative to that described in Example 1 can be used.
  • supercritical CO2 fluid solvent extraction can be used for Salvia hispanica L. seed alone or in the presence of a mixture of natural hydrophilic and lipophilic antioxidants.
  • Stabilized, partially defatted whole grain flour containing variable amounts of the unstable essential polyunsaturated fatty acid esters of ALA and LA (omega-3 and omega-6 esters) is prepared from antioxidant pretreated, pre-ground seeds of Salvia hispanica L.
  • the resulting gluten free flour provides a unique blend of protein, insoluble and soluble fiber.
  • the essential fatty acid triglycerides of alpha-linolenic acid (omega-3, “ALA”) and linoleic acid (omega-6, “LA”) are in a desirable and unique ratio of approximately 3.3:1.0 ALA to LA, along with high levels of calcium, potassium, magnesium and phosphorus.
  • the total oil content of the resulting flour can vary between about 1 and about 25 percent wt/wt of the original seed oil content of approximately 33% wt/wt.
  • the resulting flour can be incorporated into beverages, dietary supplement bars, nutritional bars, baked goods, confectionary fillings, icings, processed meats, peanut butter, jellies and the like as delivery vehicle for quantities of the essential fatty acid esters of ALA and LA, protein, soluble and insoluble fiber, and minerals depending on the amount of ALA and LA retained in the partially defatted flour and the amount of the flour employed in the end user formulation.
  • the resulting partially defatted whole grain flour is capable of re-absorbing and stabilizing relatively large quantities of other lipophilic compounds providing a convenient vehicle for delivery of these compounds in addition to ALA, LA, protein, insoluble fiber and minerals as an ingredient in food, beverage and dietary supplement based formulations.
  • the partially defatted whole grain flour can reabsorb lipophilic compounds of from about 1 to about 25 percent of the weight of the partially defatted whole grain flour, depending on the level of native seed oil remaining in the solvent extracted, whole grain flour.
  • the resulting flour also exhibits unique pH dependent thixotropic properties when added to aqueous based formulations such as beverages, including protein-based smoothies. It also provides a unique method or process for mitigating the undesirable free water associated with nutritional and dietary bar production, while providing ALA, LA, protein, soluble and insoluble fiber and minerals to such formulations and providing other lipophilic compounds depending on the composition of the flour employed.
  • composition of matter in accordance with another non-limiting aspect, is formed of a stable, partially defatted whole grain flour derived from Salvia hispanica L. whole ground seed, using a suitable solvent, and is rich in minerals and contains from about 1 to about 25 percent wt/wt of a 3.0 to 3.3:1 mixture of the essential fatty acid esters of ALA and LA, approximately 30% wt/wt protein, approximately 30-40% insoluble fiber and about 2-3% of fructo-oligosaccarides, and is also free of cyanogenic glycosides, vitamin B antagonists and gluten. It is used as a delivery vehicle for the introduction of ALA, LA, protein, soluble and insoluble protein and minerals to foods, beverages and dietary supplements. It can be used either alone or in combination with other additives to enrich the healthiness or functionality of the resulting products.
  • the composition as a product is used with a beverage or protein shake “smoothie” or nutritional bar or dietary supplement bar enriched in protein, fiber, minerals and a controlled portion of ALA and LA.
  • the product also can be used with a confectionary filling enriched in protein, fiber, minerals and a controlled portion of ALA and LA. It can also be used with an icing or processed meat or peanut butter or jelly enriched in protein, fiber, minerals and a controlled portion of ALA and LA.
  • the product can also be used with a chocolate, pectin or gelatin based confectionary or dietary supplement whose inner filling, outer shell or integrated composition is enriched in protein, fiber, minerals and a controlled portion of ALA and LA. It can be used with a pasta enriched in protein, fiber, minerals and a controlled portion of ALA and LA.
  • the composition of matter is a stable, partially defatted whole grain flour derived from Salvia hispanica L. whole ground seed, using a suitable solvent, rich in minerals, containing in combination, from about 1 to about 25 percent wt/wt of about a 3.0 to 3.3:1 mixture of the essential fatty acids ALA to LA, and absorbed lipophilic additive(s), approximately 30% wt/wt protein, approximately 30-40% of soluble and insoluble fiber and about 2-3% of fructo-oligosaccarides, which are free of cyanogenic glycosides, vitamin antagonists and gluten.
  • the composition of matter is a stable, partially defatted whole grain flour derived from Salvia hispanica L. whole ground seed, using a suitable solvent, rich in minerals, containing, in combination, a total of from about 1 to about 25 percent wt/wt of about a 3.0 to 3.3:1 mixture of the essential fatty acids ALA to LA, and an absorbed hydrophilic additive, approximately 30% wt/wt protein, approximately 30-40% of soluble and insoluble fiber and about 2 to about 3 percent of fructo-oligosaccarides and free of cyanogenic glycosides, vitamin antagonists and gluten, used as a delivery vehicle for the introduction of ALA, LA, protein, soluble and insoluble protein, minerals and lipophilic additives to foods, beverages and dietary supplements. It is used either alone or in combination with other additives to enhance the healthiness or functionality of the resulting products.
  • the resulting flour can be incorporated into beverages, dietary supplement bars, nutritional bars, baked goods, confectionary fillings, icings, processed meats, peanut butter, jellies and the like as a partially soluble delivery vehicle for heart healthy quantities of the essential fatty acids ALA and LA, protein and soluble and insoluble fiber depending on the amount employed in the end user formulation.
  • the composition of matter is formed as a stable, partially defatted whole grain flour derived from Salvia hispanica L. whole ground seed using a suitable solvent which is free of cyanogenic glycosides, vitamin antagonists, gluten, rich in minerals and containing from about 1 to about 25 percent wt/wt of about a 3.0 to 3.3:1 mixture of ALA to LA native seed oil, approximately 30% wt/wt protein and approximately 30-40% insoluble fiber and 2-3% of fructo-oligosaccarides.
  • the composition exhibits pH dependent thixotropic properties when admixed in water bearing compositions
  • the composition can be formed as partially defatted whole grain flour derived from Salvia hispanica L. whole ground seed containing from about 1 to about 25 percent wt/wt of a mixture containing ALA and LA fatty acid esters, protein, insoluble fiber, minerals and other lipophilic additives such as DHA or EPA fatty acid esters or other health or functional lipophilic compounds.
  • it can include lipophilic compounds reabsorbed into the flour including one of at least rosemary oil, tocopherols, tocotrienols, carotenoids, seed oils, lipophilic solvent extracted botanical oils, lipophilic food flavorings or other health or functional hydrophilic compounds.
  • the composition can include hydrophilic additives re-absorbed into the flour such as, for example, hydrophilic solvent extracts of botanicals, green tea extract, grape seed extract, ascorbic acid, caffeine, mono and/or polysaccharides, gums, phospholipids, biopolymers, hydrophilic food flavorings or other health or functional hydrophilic compounds.
  • hydrophilic additives re-absorbed into the flour such as, for example, hydrophilic solvent extracts of botanicals, green tea extract, grape seed extract, ascorbic acid, caffeine, mono and/or polysaccharides, gums, phospholipids, biopolymers, hydrophilic food flavorings or other health or functional hydrophilic compounds.
  • the composition has been pretreated with a suitable proteolytic enzyme or plurality of enzymes to produce a novel probiotic mixture rich in essential amino acids.
  • supercritical CO 2 fluid extraction is used on Salvia hispanica L. seed alone or in the presence of a mixture of naturally available hydrophilic and lipophilic antioxidants. It is possible to prepare a completely defatted whole grain flour from pretreated pre-ground seeds of Salvia hispanica L. The resulting gluten free flour provides a unique blend of protein, insoluble and soluble fiber, along with high levels of the minerals calcium, potassium, magnesium and phosphorus.
  • the resulting flour can also be incorporated into beverages, dietary supplement bars, nutritional bars, baked goods, confectionary fillings, icings, processed meats, peanut butter, jellies, bakery goods and the like as a delivery vehicle for protein, soluble and insoluble fiber and minerals or as a dessicant in food applications where excess water creates a formulation problem.
  • the resulting defatted whole grain flour is capable of re-absorbing and stabilizing relatively large quantities of other lipophilic compounds providing a convenient vehicle for delivery of these compounds in addition to protein soluble and insoluble fiber and minerals as an ingredient in food, beverage and dietary supplement based formulations.
  • the defatted whole grain flour can re-absorb lipophilic compounds of about 1 to about 25 percent of the weight of the defatted whole grain flour.
  • the resulting defatted whole grain flour exhibits the ability to reabsorb large quantities of lipophilic as well as hydrophilic additives, while exhibiting a pH dependent thixotropic effect when subjected to aqueous environments.
  • the defatted flour is a novel food, beverage or dietary supplement ingredient delivery vehicle for lipophilic and hydrophilic additives in the presence of protein, fiber and minerals that are free of cyanogenic glycosides, vitamin B antagonists, lignin and gluten.
  • the composition of matter can be formed as a stable, completely defatted whole grain flour derived from Salvia hispanica L. whole ground seed using a suitable solvent which is free of cyanogenic glycosides, vitamin, antagonists, gluten, and contains minerals, approximately 30% wt/wt protein, approximately 30-40% insoluble fiber and 2-3% of fructo-oligosaccarides.
  • Lipophilic compounds can be reabsorbed into the flour such as, for example, rosemary oil, tocopherols, tocotrienols, carotenoids, seed oils, lipophilic solvent extracted botanical oils, lipophilic food flavorings, polyunsaturated fatty acid esters or other health or functional hydrophilic compounds. It can be admixed with hydrophilic additives re-absorbed into the flour such as, for example, hydrophilic solvent extracts of botanicals, green tea extract, grape seed extract, ascorbic acid, caffeine, mono and or polysaccharides, gums, phospholipids, biopolymers, hydrophilic food flavorings or other health or functional hydrophilic compounds.
  • the composition can be pretreated with a suitable proteolytic enzyme or plurality of enzymes to produce a probiotic mixture rich in essential amino acids. It can be pretreated with a suitable enzyme or enzymes, which degrade the soluble and insoluble fiber to produce a probiotic mixture rich in digestible monosaccharide and oligosaccharide units.
  • the composition of matter is formed as a a stable, defatted whole grain flour derived from Salvia hispanica L. whole ground seed, using a suitable solvent, rich in minerals and approximately 30% wt/wt protein, approximately 30-40% insoluble fiber and about 2-3% of fructo-oligosaccarides free of cyanogenic glycosides with vitamin B antagonists and gluten as a delivery vehicle for the introduction of protein, soluble and insoluble protein and minerals to foods, beverages and dietary supplements, either alone or in combination with other additives, to enrich the healthiness or functionality of the resulting products.
  • the composition of matter can be formed as a product in beverage or protein shake “smoothie” form and enriched in protein, fiber, and minerals.
  • the final product can be a nutritional bar or a dietary supplement bar enriched in protein, fiber, and minerals. It can also be used with a confectionary filling or peanut butter or jelly enriched in protein, fiber, minerals or an icing or processed meat enriched in protein, fiber, minerals and a controlled portion of ALA and LA. In another example, it can also be used with a product such as a chocolate, pectin or gelatin based confectionary or dietary supplement whose inner filling, outer shell or integrated composition is enriched in protein, fiber, and minerals. The product can also be used with a pasta enriched in protein, fiber, and minerals.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
US12/349,123 2008-01-11 2009-01-06 Chia seed beverage and related method Abandoned US20090181114A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/349,123 US20090181114A1 (en) 2008-01-11 2009-01-06 Chia seed beverage and related method
PCT/US2009/030577 WO2009089432A1 (fr) 2008-01-11 2009-01-09 Boisson à graine de chia et procédé apparenté

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US2051908P 2008-01-11 2008-01-11
US2053908P 2008-01-11 2008-01-11
US2050008P 2008-01-11 2008-01-11
US2058308P 2008-01-11 2008-01-11
US2059008P 2008-01-11 2008-01-11
US12/349,123 US20090181114A1 (en) 2008-01-11 2009-01-06 Chia seed beverage and related method

Publications (1)

Publication Number Publication Date
US20090181114A1 true US20090181114A1 (en) 2009-07-16

Family

ID=40850844

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/349,123 Abandoned US20090181114A1 (en) 2008-01-11 2009-01-06 Chia seed beverage and related method
US12/349,100 Expired - Fee Related US8652544B2 (en) 2008-01-11 2009-01-06 Chia seed composition
US14/094,867 Expired - Fee Related US9131726B2 (en) 2008-01-11 2013-12-03 Chia seed composition

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/349,100 Expired - Fee Related US8652544B2 (en) 2008-01-11 2009-01-06 Chia seed composition
US14/094,867 Expired - Fee Related US9131726B2 (en) 2008-01-11 2013-12-03 Chia seed composition

Country Status (6)

Country Link
US (3) US20090181114A1 (fr)
KR (2) KR20130041388A (fr)
AU (1) AU2009204095B2 (fr)
DE (2) DE202009018158U1 (fr)
NZ (1) NZ586602A (fr)
WO (2) WO2009089436A1 (fr)

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100189875A1 (en) * 2009-01-29 2010-07-29 Brunob Ii B.V. Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
WO2011011604A2 (fr) 2009-07-23 2011-01-27 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour atténuer la douleur articulaire
WO2011089525A2 (fr) * 2010-01-25 2011-07-28 Dean Mosca Concentré de protéine de la graine de salvia hispanica
US20110195061A1 (en) * 2009-07-23 2011-08-11 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha
WO2011137160A2 (fr) 2010-04-30 2011-11-03 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et méthode permettant d'améliorer le profil des lipides dans le sang et de réduire éventuellement la peroxydation des lipoprotéines de faible densité (ldl) chez l'homme
WO2011136885A2 (fr) * 2010-03-23 2011-11-03 Jeffrey Walters Rehausseur de texture et de goût et utilisation dans la préparation des aliments
WO2011139906A2 (fr) * 2010-04-29 2011-11-10 Mary's Gone Crackers Procédé d'émulsification et de texturation d'un produit végétalien sans gluten
US20140205675A1 (en) * 2008-01-11 2014-07-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Horse feed dietary supplement composition derived from chia seed composition
WO2014197214A1 (fr) * 2013-06-05 2014-12-11 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition comprenant de la farine de graines de périlla
US8993012B2 (en) 2008-04-10 2015-03-31 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
CN104509589A (zh) * 2013-09-30 2015-04-15 内蒙古伊利实业集团股份有限公司 一种添加奇亚籽的酸奶及其制备方法
CN104509588A (zh) * 2013-09-30 2015-04-15 内蒙古伊利实业集团股份有限公司 一种天然稳定的酸奶及其制备方法
WO2015067967A1 (fr) * 2013-11-08 2015-05-14 Johnston-Murphy Sandra Aliment pour animaux
JP2015517800A (ja) * 2012-03-02 2015-06-25 ペプシコ, インコーポレイテッドPepsiCo Inc. タンパク質飲料を製造する方法および変性ループ装置とシステム
US9114142B2 (en) 2008-04-10 2015-08-25 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
KR101551323B1 (ko) * 2013-06-12 2015-09-08 주식회사 엘지생활건강 수화 치아시드를 포함한 음료 제조방법
US9131726B2 (en) 2008-01-11 2015-09-15 U.S. Nutraceuticals, LLC Chia seed composition
WO2015142700A1 (fr) 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé destinés à atténuer la douleur articulaire au moyen de phospholipides et d'astaxanthine
WO2015142702A1 (fr) 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour soulager les douleurs articulaires au moyen de phospholipides et d'extrait d'œufs de poisson
WO2015143001A1 (fr) 2014-03-19 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition d'astaxanthine thérapeutique et de phospholipide et procédé associé
WO2015142705A1 (fr) 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour soulager une douleur articulaire au moyen d'huiles à base d'algues
GB2526185A (en) * 2014-03-24 2015-11-18 Us Nutraceuticals Llc Dba Valensa Int Horse feed dietary supplement composition derived from chia seed composition
WO2015175478A1 (fr) 2014-05-13 2015-11-19 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition employant des extraits d'huile de graines et des phospholipides pour améliorer l'absorption de caroténoïdes et procédés associés
US9192671B2 (en) 2010-04-30 2015-11-24 U.S. Nutraceuticals, LLC Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans
US9216164B2 (en) 2009-07-23 2015-12-22 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9238043B2 (en) 2009-07-23 2016-01-19 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using algae based oils
WO2016053076A1 (fr) * 2014-10-02 2016-04-07 SELDNER LIZARRAGA, Hector Jesus Boisson de type orgeat enrichie d'une protéine et d'un stabilisateur naturel
KR20160081477A (ko) * 2014-12-31 2016-07-08 주식회사 풀무원 치아씨드를 함유하는 츄어블 오메가 3 음료의 제조 방법
US9399047B2 (en) 2009-07-23 2016-07-26 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and roe extract
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
US9414620B2 (en) 2008-04-10 2016-08-16 U.S. Nutraceuticals, LLC Perilla seed composition
US20170079310A1 (en) * 2015-09-18 2017-03-23 Richard Gerry Dingman, JR. Texture analog dysphagia cuisine
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US9763897B2 (en) 2010-04-30 2017-09-19 U.S. Nutraceuticals, LLC Therapeutic astaxanthin and phospholipid composition and associated method
CN107751971A (zh) * 2016-08-19 2018-03-06 内蒙古伊利实业集团股份有限公司 一种保持果酱或果味酱中果粒口感的方法
US9913810B2 (en) 2009-07-23 2018-03-13 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and astaxanthin
DE202018105422U1 (de) 2018-06-21 2018-10-19 U.S. Nutraceuticals, Llc D/B/A Valensa International Zusammensetzung zur Linderung von Gelenkschmerzen unter Verwendung von Hyaluronsäure und Eierschalenmembrankomponenten
DE202018105987U1 (de) 2018-05-24 2018-12-19 U.S. Nutraceuticals, Llc D/B/A Valensa International Zusammensetzung zur Linderung von Gelenkschmerzen unter Verwendung von Hyaluronsäure und Eierschalenmembrankomponenten
WO2019083732A1 (fr) 2017-10-23 2019-05-02 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition destinée au traitement de la fatigue oculaire photo-induite et de la réduction associée de vitesse de focalisation oculaire chez l'être humain
JP2019520454A (ja) * 2016-06-07 2019-07-18 モリーニ、アンジェロ 水で戻すことができかつ水溶性のチア生成物及び関連する製造方法
JP2019536865A (ja) * 2016-11-17 2019-12-19 アピール テクノロジー,インコーポレイテッド 植物抽出物から形成される組成物及びその調製方法
RU2718828C1 (ru) * 2019-01-17 2020-04-14 Татьяна Николаевна Алексеева Безалкогольный напиток
CN113508837A (zh) * 2020-04-10 2021-10-19 内蒙古蒙牛乳业(集团)股份有限公司 含有裸藻粉和奇亚籽粉的乳酸菌饮料及其制备方法
US11160287B2 (en) 2015-05-20 2021-11-02 Apeel Technology, Inc. Plant extract compositions and methods of preparation thereof
US11470869B2 (en) * 2017-07-26 2022-10-18 Wenching Grace Lu Food product, including Boba (bubble, pearl) beverage replacing tapioca with chia seed as the main ingredient
US11767278B2 (en) 2015-12-10 2023-09-26 Apeel Technology, Inc. Plant extract compositions for forming protective coatings
US11827591B2 (en) 2020-10-30 2023-11-28 Apeel Technology, Inc. Compositions and methods of preparation thereof

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140120234A1 (en) * 2008-01-11 2014-05-01 U.S. Nutraceuticals, Llc D/B/A Valensa International Chia seed composition
US8252354B2 (en) * 2009-06-08 2012-08-28 Mas Marketing Holding Company, Llc Manufacture of seed derivative compositions
US8685472B2 (en) 2010-03-01 2014-04-01 Access Business Group International Llc Skin whitening composition containing chia seed extract
US8409636B2 (en) 2010-09-29 2013-04-02 Access Business Group International Llc Chia seed extract and related method of manufacture
WO2013106647A1 (fr) 2012-01-13 2013-07-18 Dharma Biomedical, Llc Extraits de guggul supercritiques et leurs utilisations
BR102012007248A2 (pt) * 2012-03-30 2013-11-19 Sueli Coutinho Nogueira Formulação de produto funcional tipo bombom com semente de chia e amaranto
WO2017180174A1 (fr) 2016-04-15 2017-10-19 Fairhaven Health, Llc Compositions et procédés pour maintenir ou améliorer l'homéostasie ou la fonction du tractus génital féminin inférieur
ES2849424T3 (es) 2016-06-05 2021-08-18 Mondelez Europe Gmbh Composición de alimento sabroso horneado que comprende vegetales de raíz desmenuzada y método para elaborar el mismo
RU2669292C1 (ru) * 2017-11-10 2018-10-09 Александр Александрович Кролевец Способ производства мороженого с наноструктурированными семенами чиа
CN107912667B (zh) * 2017-12-20 2021-03-30 内蒙古蒙牛乳业(集团)股份有限公司 奇亚籽饮品及其制备方法
CN107996726A (zh) * 2017-12-22 2018-05-08 慧宁(天津)欧米伽三科技有限公司 奇亚籽植物蛋白饮料及其制备方法
USD864516S1 (en) 2018-05-14 2019-10-29 Intercontinental Great Brands Llc Thin food cluster
CN110693942B (zh) * 2019-10-23 2022-01-28 山东中医药大学 奇亚籽在制备抑制肠道蠕动的药品中的应用

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332803A (en) * 1992-04-22 1994-07-26 Nisshin Flour Milling Co., Ltd. Processes for the preparation of amylase inhibitor
US5498434A (en) * 1992-02-21 1996-03-12 Geo. Pfau's Sons Company, Inc. Synergistic compositions for extending animal feed shelf life
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
US6123695A (en) * 1995-07-07 2000-09-26 Sca Hygiene Products Ab Absorbent article with mechanical buckle
US20020155182A1 (en) * 2001-03-08 2002-10-24 David Belna Chia seed beverage and method
US20020168431A1 (en) * 2001-03-07 2002-11-14 David Belna Methods for the treatment and prevention of metabolic diseases including diabetes
US20030175403A1 (en) * 2002-03-14 2003-09-18 Gurin Michael H. Potentiated bioactive additives and method of use
US20040137132A1 (en) * 2002-12-02 2004-07-15 Nunez Daniel Alfonso Procedure to obtain a product consisting in a partially low-fat flour with a high content of stabilized, polyunsaturated fatty acids, especially omega3
US20040185129A1 (en) * 2001-03-09 2004-09-23 Vladimir Vuksan Salvia hispanica l (chia) in the management and treatment of cardiovascular disease diabetes and asociated risk factors
US6827965B1 (en) * 1992-05-05 2004-12-07 Michael Fitzpatrick Food products containing whole chia seed or a gluten-free agglutinant derived therefrom and methods of making same
US20050137132A1 (en) * 2002-09-20 2005-06-23 University Of Utah Research Foundation Uses of novel potassium channel blockers
US20050147698A1 (en) * 2002-03-28 2005-07-07 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
US20050185129A1 (en) * 2004-02-25 2005-08-25 Lg.Philips Lcd Co., Ltd. Liquid crystal display device and method of fabricating the same
US20080095881A1 (en) * 2006-09-29 2008-04-24 Garden Of Life, Inc. Fiber and natural chelator composition suitable for effective detoxification

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4493854A (en) 1983-09-20 1985-01-15 The United States Of America As Represented By The Secretary Of Agriculture Production of defatted soybean products by supercritical fluid extraction
US5985312A (en) * 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
DE19809893B4 (de) 1998-03-07 2004-06-03 Jodlbauer, Heinz D., Dr. Verfahren zur Herstellung eines Nahrungsergänzungsmittels aus Perillasamen
WO1999062356A1 (fr) 1998-06-03 1999-12-09 Wayne Coates Supplement dietetique pour l'homme
DE10021384A1 (de) * 2000-05-03 2001-11-15 Hora Reiner Ergänzungsfutter für Haustiere
US7879377B2 (en) * 2002-04-18 2011-02-01 Nestec, Ltd. Pet snack
US7488501B2 (en) * 2002-07-12 2009-02-10 The Texas A&M University System Enzymatic process for generation of foods, feedstuffs and ingredients therefor
AU2003267122A1 (en) 2002-09-09 2004-03-29 Sourcepharm, Inc. Chia seeds
DK1694137T3 (da) * 2003-11-26 2009-04-27 Hills Pet Nutrition Inc Fremgangsm de til at reducere lugt af aff ring fra k ledyr
US20050281937A1 (en) * 2004-06-22 2005-12-22 Sarma Monoj K Reduced-fat flavored edible oil spreads
US20060260537A1 (en) * 2005-05-20 2006-11-23 The Iams Company Wet pet food products and method for preparation
US20080008786A1 (en) * 2006-07-10 2008-01-10 Sevilla Arlene H Edible Greeting Object for Pets
US20090181114A1 (en) 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Chia seed beverage and related method
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498434A (en) * 1992-02-21 1996-03-12 Geo. Pfau's Sons Company, Inc. Synergistic compositions for extending animal feed shelf life
US5332803A (en) * 1992-04-22 1994-07-26 Nisshin Flour Milling Co., Ltd. Processes for the preparation of amylase inhibitor
US6827965B1 (en) * 1992-05-05 2004-12-07 Michael Fitzpatrick Food products containing whole chia seed or a gluten-free agglutinant derived therefrom and methods of making same
US6123695A (en) * 1995-07-07 2000-09-26 Sca Hygiene Products Ab Absorbent article with mechanical buckle
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
US20020168431A1 (en) * 2001-03-07 2002-11-14 David Belna Methods for the treatment and prevention of metabolic diseases including diabetes
US20020155182A1 (en) * 2001-03-08 2002-10-24 David Belna Chia seed beverage and method
US20040185129A1 (en) * 2001-03-09 2004-09-23 Vladimir Vuksan Salvia hispanica l (chia) in the management and treatment of cardiovascular disease diabetes and asociated risk factors
US20080305190A1 (en) * 2001-03-09 2008-12-11 Vladimir Vuksan Salvia hispanica I (Chia) in the management and treatment of cardiovascular disease, diabetes and associated risk factors
US20030175403A1 (en) * 2002-03-14 2003-09-18 Gurin Michael H. Potentiated bioactive additives and method of use
US20050147698A1 (en) * 2002-03-28 2005-07-07 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
US20050137132A1 (en) * 2002-09-20 2005-06-23 University Of Utah Research Foundation Uses of novel potassium channel blockers
US20040137132A1 (en) * 2002-12-02 2004-07-15 Nunez Daniel Alfonso Procedure to obtain a product consisting in a partially low-fat flour with a high content of stabilized, polyunsaturated fatty acids, especially omega3
US20050185129A1 (en) * 2004-02-25 2005-08-25 Lg.Philips Lcd Co., Ltd. Liquid crystal display device and method of fabricating the same
US20080095881A1 (en) * 2006-09-29 2008-04-24 Garden Of Life, Inc. Fiber and natural chelator composition suitable for effective detoxification

Cited By (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140205675A1 (en) * 2008-01-11 2014-07-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Horse feed dietary supplement composition derived from chia seed composition
US9161960B2 (en) * 2008-01-11 2015-10-20 U.S. Nutraceuticals, LLC Horse feed dietary supplement composition derived from chia seed composition
US9131726B2 (en) 2008-01-11 2015-09-15 U.S. Nutraceuticals, LLC Chia seed composition
US9414620B2 (en) 2008-04-10 2016-08-16 U.S. Nutraceuticals, LLC Perilla seed composition
US9511106B2 (en) 2008-04-10 2016-12-06 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US9532965B2 (en) 2008-04-10 2017-01-03 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US9138452B2 (en) 2008-04-10 2015-09-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from Perilla seed: composition of matter, manufacturing process and use
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US9114142B2 (en) 2008-04-10 2015-08-25 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US8993012B2 (en) 2008-04-10 2015-03-31 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US20100189875A1 (en) * 2009-01-29 2010-07-29 Brunob Ii B.V. Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
US8999373B2 (en) 2009-07-23 2015-04-07 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9675635B2 (en) 2009-07-23 2017-06-13 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and joint care components, including type II collagen
US8557275B2 (en) 2009-07-23 2013-10-15 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US8507757B2 (en) 2009-07-23 2013-08-13 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain
US9974756B2 (en) 2009-07-23 2018-05-22 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and astaxanthin
US8945608B2 (en) 2009-07-23 2015-02-03 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain
US8962924B2 (en) 2009-07-23 2015-02-24 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain
US8481072B2 (en) 2009-07-23 2013-07-09 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain
US9216164B2 (en) 2009-07-23 2015-12-22 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9913810B2 (en) 2009-07-23 2018-03-13 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and astaxanthin
US9795631B2 (en) 2009-07-23 2017-10-24 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
US9028814B2 (en) 2009-07-23 2015-05-12 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
WO2011011604A2 (fr) 2009-07-23 2011-01-27 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour atténuer la douleur articulaire
US9034366B2 (en) 2009-07-23 2015-05-19 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9050364B2 (en) 2009-07-23 2015-06-09 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US8524980B2 (en) 2009-07-23 2013-09-03 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain
EP2902033A1 (fr) 2009-07-23 2015-08-05 U.S. Nutraceuticals LLC dba Valensa International Composition et procédé pour soulager une douleur articulaire
US9238043B2 (en) 2009-07-23 2016-01-19 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using algae based oils
US9399047B2 (en) 2009-07-23 2016-07-26 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and roe extract
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
US20110195061A1 (en) * 2009-07-23 2011-08-11 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha
US9597300B2 (en) 2009-07-23 2017-03-21 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9597305B2 (en) 2009-07-23 2017-03-21 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US10624919B2 (en) 2009-07-23 2020-04-21 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
WO2011089525A3 (fr) * 2010-01-25 2011-09-29 Dean Mosca Concentré de protéine de la graine de salvia hispanica
WO2011089525A2 (fr) * 2010-01-25 2011-07-28 Dean Mosca Concentré de protéine de la graine de salvia hispanica
WO2011136885A2 (fr) * 2010-03-23 2011-11-03 Jeffrey Walters Rehausseur de texture et de goût et utilisation dans la préparation des aliments
WO2011136885A3 (fr) * 2010-03-23 2012-01-12 Jeffrey Walters Rehausseur de texture et de goût et utilisation dans la préparation des aliments
US20130095213A1 (en) * 2010-03-23 2013-04-18 Jeffrey Walters Texture and Flavor Enhancer and Use in Food Preparation
WO2011139906A2 (fr) * 2010-04-29 2011-11-10 Mary's Gone Crackers Procédé d'émulsification et de texturation d'un produit végétalien sans gluten
WO2011139906A3 (fr) * 2010-04-29 2012-02-23 Mary's Gone Crackers Procédé d'émulsification et de texturation d'un produit végétalien sans gluten
US9192671B2 (en) 2010-04-30 2015-11-24 U.S. Nutraceuticals, LLC Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans
US9763897B2 (en) 2010-04-30 2017-09-19 U.S. Nutraceuticals, LLC Therapeutic astaxanthin and phospholipid composition and associated method
WO2011137160A2 (fr) 2010-04-30 2011-11-03 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et méthode permettant d'améliorer le profil des lipides dans le sang et de réduire éventuellement la peroxydation des lipoprotéines de faible densité (ldl) chez l'homme
JP2015517800A (ja) * 2012-03-02 2015-06-25 ペプシコ, インコーポレイテッドPepsiCo Inc. タンパク質飲料を製造する方法および変性ループ装置とシステム
WO2014197214A1 (fr) * 2013-06-05 2014-12-11 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition comprenant de la farine de graines de périlla
KR101551323B1 (ko) * 2013-06-12 2015-09-08 주식회사 엘지생활건강 수화 치아시드를 포함한 음료 제조방법
CN104509589A (zh) * 2013-09-30 2015-04-15 内蒙古伊利实业集团股份有限公司 一种添加奇亚籽的酸奶及其制备方法
CN104509588A (zh) * 2013-09-30 2015-04-15 内蒙古伊利实业集团股份有限公司 一种天然稳定的酸奶及其制备方法
WO2015067967A1 (fr) * 2013-11-08 2015-05-14 Johnston-Murphy Sandra Aliment pour animaux
WO2015142705A1 (fr) 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour soulager une douleur articulaire au moyen d'huiles à base d'algues
DE212015000076U1 (de) 2014-03-18 2016-12-06 U.S. Nutraceuticals Llc Dba Valensa International Zusammensetzung zum Mildern von Gelenkschmerzen mittels niedermolekulargewichtiger Hyaluronsäure und Astaxanthin
DE212015000073U1 (de) 2014-03-18 2016-12-06 U.S. Nutraceuticals Llc Dba Valensa International Zusammensetzung zum Mildern von Gelenkschmerzen mittels Phopholipiden und Astaxanthin
WO2015142700A1 (fr) 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé destinés à atténuer la douleur articulaire au moyen de phospholipides et d'astaxanthine
WO2015142707A1 (fr) 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour soulager la douleur articulaire au moyen d'acide hyaluronique de faible poids moléculaire et d'astaxanthine
WO2015142702A1 (fr) 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour soulager les douleurs articulaires au moyen de phospholipides et d'extrait d'œufs de poisson
WO2015143001A1 (fr) 2014-03-19 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition d'astaxanthine thérapeutique et de phospholipide et procédé associé
DE212015000033U1 (de) 2014-03-19 2016-08-26 U.S. Nutraceuticals, Llc D/B/A Valensa International Therapeutische Astaxanthin- und Phospholipidzusammensetzung
WO2015142999A1 (fr) 2014-03-19 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour améliorer les profils lipidiques sanguins et réduire la peroxydation des lipoprotéines basse densité (ldl) chez les humains au moyen d'huiles à base d'algues et d'astaxanthine
GB2526185A (en) * 2014-03-24 2015-11-18 Us Nutraceuticals Llc Dba Valensa Int Horse feed dietary supplement composition derived from chia seed composition
DE212015000031U1 (de) 2014-05-13 2017-02-20 U.S. Nutraceuticals, Llc D/B/A Valensa International Zusammensetzung, die Samenölextrakte und Phospholipide verwendet, um die Absorption von Carotinoiden zu verbessern
WO2015175478A1 (fr) 2014-05-13 2015-11-19 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition employant des extraits d'huile de graines et des phospholipides pour améliorer l'absorption de caroténoïdes et procédés associés
WO2016053076A1 (fr) * 2014-10-02 2016-04-07 SELDNER LIZARRAGA, Hector Jesus Boisson de type orgeat enrichie d'une protéine et d'un stabilisateur naturel
KR101692892B1 (ko) * 2014-12-31 2017-01-04 주식회사 풀무원 치아씨드를 함유하는 츄어블 오메가 3 음료의 제조 방법
KR20160081477A (ko) * 2014-12-31 2016-07-08 주식회사 풀무원 치아씨드를 함유하는 츄어블 오메가 3 음료의 제조 방법
US11812758B2 (en) 2015-05-20 2023-11-14 Apeel Technology, Inc. Plant extract compositions and methods of preparation thereof
US11160287B2 (en) 2015-05-20 2021-11-02 Apeel Technology, Inc. Plant extract compositions and methods of preparation thereof
US20170079310A1 (en) * 2015-09-18 2017-03-23 Richard Gerry Dingman, JR. Texture analog dysphagia cuisine
US11767278B2 (en) 2015-12-10 2023-09-26 Apeel Technology, Inc. Plant extract compositions for forming protective coatings
JP2019520454A (ja) * 2016-06-07 2019-07-18 モリーニ、アンジェロ 水で戻すことができかつ水溶性のチア生成物及び関連する製造方法
CN107751971A (zh) * 2016-08-19 2018-03-06 内蒙古伊利实业集团股份有限公司 一种保持果酱或果味酱中果粒口感的方法
US11319275B2 (en) 2016-11-17 2022-05-03 Apeel Technology, Inc. Compositions formed from plant extracts and methods of preparation thereof
JP2019536865A (ja) * 2016-11-17 2019-12-19 アピール テクノロジー,インコーポレイテッド 植物抽出物から形成される組成物及びその調製方法
US11918003B2 (en) 2016-11-17 2024-03-05 Apeel Technology, Inc. Compositions formed from plant extracts and methods of preparation thereof
JP7194678B2 (ja) 2016-11-17 2022-12-22 アピール テクノロジー,インコーポレイテッド 植物抽出物から形成される組成物及びその調製方法
US11470869B2 (en) * 2017-07-26 2022-10-18 Wenching Grace Lu Food product, including Boba (bubble, pearl) beverage replacing tapioca with chia seed as the main ingredient
WO2019083732A1 (fr) 2017-10-23 2019-05-02 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition destinée au traitement de la fatigue oculaire photo-induite et de la réduction associée de vitesse de focalisation oculaire chez l'être humain
DE202018105987U1 (de) 2018-05-24 2018-12-19 U.S. Nutraceuticals, Llc D/B/A Valensa International Zusammensetzung zur Linderung von Gelenkschmerzen unter Verwendung von Hyaluronsäure und Eierschalenmembrankomponenten
WO2019226186A1 (fr) 2018-05-24 2019-11-28 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition et procédé pour soulager les douleurs articulaires au moyen d'acide hyaluronique et de composants de membrane de coquille d'œuf
DE202018105422U1 (de) 2018-06-21 2018-10-19 U.S. Nutraceuticals, Llc D/B/A Valensa International Zusammensetzung zur Linderung von Gelenkschmerzen unter Verwendung von Hyaluronsäure und Eierschalenmembrankomponenten
RU2718828C1 (ru) * 2019-01-17 2020-04-14 Татьяна Николаевна Алексеева Безалкогольный напиток
CN113508837A (zh) * 2020-04-10 2021-10-19 内蒙古蒙牛乳业(集团)股份有限公司 含有裸藻粉和奇亚籽粉的乳酸菌饮料及其制备方法
US11827591B2 (en) 2020-10-30 2023-11-28 Apeel Technology, Inc. Compositions and methods of preparation thereof

Also Published As

Publication number Publication date
US20140087050A1 (en) 2014-03-27
DE202009018158U1 (de) 2011-03-31
KR20130041388A (ko) 2013-04-24
AU2009204095A1 (en) 2009-07-16
WO2009089436A1 (fr) 2009-07-16
US8652544B2 (en) 2014-02-18
US20090181127A1 (en) 2009-07-16
WO2009089432A1 (fr) 2009-07-16
US9131726B2 (en) 2015-09-15
AU2009204095B2 (en) 2011-05-26
DE112009000124T5 (de) 2011-02-03
KR20100107498A (ko) 2010-10-05
NZ586602A (en) 2011-11-25

Similar Documents

Publication Publication Date Title
US9131726B2 (en) Chia seed composition
JP6504199B2 (ja) タンパク質素材およびその製造法
CN101394756A (zh) 具有改善的味觉印象的食品和饮品
US20170013855A1 (en) Food using soybean powder and method for manufacturing thereof
Ansari et al. Fortification of food and beverages with phytonutrients.
RU2608227C2 (ru) Композиция с текстурой йогурта
Atallah et al. Preparation of non-dairy soft ice milk with soy milk
US9161960B2 (en) Horse feed dietary supplement composition derived from chia seed composition
Tallapragada et al. Recent trends and developments in milk-based beverages
US20140120234A1 (en) Chia seed composition
JP3892144B2 (ja) ココア組成物
AU2011211461B2 (en) Chia seed composition
RU2525338C2 (ru) Инстантный функциональный пищевой продукт
KR20220008475A (ko) 체중조절용 식품 조성물
Beşir et al. A Plant-Based Milk Type: Hemp Seed Milk
AU2015201182B2 (en) Horse feed dietary supplement composition derived from chia seed composition
JP2020068712A (ja) 乳風味を有する乳化組成物、その製造方法および乳風味を有する乳化組成物の香味を改良する方法
Özbek et al. Chapter 3. Utilisation of oilseed meals in food industry
Jeske Evaluation and improvement of technological and nutritional properties of plant-based milk substitutes
JP7256215B2 (ja) 豆乳飲料およびその製造方法
KR100982012B1 (ko) 커피믹스 및 그 제조방법
Zommara et al. Chufa Drink: Developing a New Plant-Based Beverages with Different Flavours
Zommara et al. Journal of Sustainable Agricultural Science
Campos-Vega et al. Designer food and feeds from underutilized fruits and vegetables
JP2023072945A (ja) 植物性タンパク含有飲料、植物性タンパク含有飲料の作製方法、および植物性タンパク含有飲料用組成物

Legal Events

Date Code Title Description
AS Assignment

Owner name: U.S. NUTRACEUTICALS LLC DBA VALENSA INTERNATIONAL,

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MINATELLI, JOHN A.;HILL, W. STEPHEN;MOERCK, RUDI;AND OTHERS;REEL/FRAME:022284/0929;SIGNING DATES FROM 20090112 TO 20090119

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION